Durect Corp (DRRX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Felix Theeuwes
Employees:
88
10260 BUBB RD, CUPERTINO, CA 95014
4087771417

DURECT Corp. operates as a biopharmaceutical company. It engages in the development of therapeutics based on its proprietary drug delivery technology platforms. Its brands include ALZET, a osmotic pumps, which is used in laboratory research; and LACTEL, a biodegradable polymers, which is used by pharmaceutical and medical device clients for use as raw materials in their products. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.

Data derived from most recent annual or quarterly report
Market Cap 252.521 Million Shares Outstanding227.496 Million Avg 30-day Volume 651.608 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue14.6532 Debt to Equity0.2564 EBITDA-11.828 Million
Price to Book Value5.5096 Operating Margin-40.4908 Enterprise Value373.988 Million
Current Ratio8.955 EPS Growth1.385 Quick Ratio8.38
1 Yr BETA 52-week High/Low 2.95 / 1.02 Profit Margin-2.4993
Operating Cash Flow Growth-1037.9779 Altman Z-Score2.7205 Free Cash Flow to Firm -32.212 Million
View SEC Filings from DRRX instead.

View recent insider trading info

Funds Holding DRRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DRRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOFFMANN DAVE

  • Director
55,000 2021-06-15 1

BENITO SIMON X

  • Director
55,000 2021-06-15 1

AZAB MOHAMMAD

  • Director
27,500 2021-06-15 3

BLASCHKE TERRENCE F

  • Director
55,000 2021-06-15 1

MADERIS GAIL J

  • Director
27,500 2021-06-15 3

FARFEL GAIL M

  • Director
55,000 2021-06-15 1

ROBERTSON JUDITH J.

  • Director
55,000 2021-06-15 1

JOICE JUDY R SR. VP OPERATIONS & CORP QA

  • Officer
34,832 2021-05-14 2

BROWN JAMES E PRESIDENT & CEO

  • Officer
  • Director
0 2021-01-15 1

SUSSMAN NORMAN CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-15 1

ARENBERG MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-15 1

BLEICHROEDER LP

  • 10% Owner
26,414,656 2020-09-01 0

SAXE JON S

  • Director
0 2020-06-17 0

NEUKERMANS ARMAND

  • Director
0 2020-06-17 0

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
No longer subject to file 2019-09-01 0

FIRST EAGLE INVESTMENT MANAGEMENT, LLC

21 APRIL FUND, L.P.

21 APRIL FUND, LTD.

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
26,476,546 2019-06-20 0

THEEUWES FELIX CHAIRMAN AND CSO

  • Officer
  • Director
0 2018-01-26 0

HOGAN MATTHEW J CHIEF FINANCIAL OFFICER

  • Officer
0 2018-01-26 0

21 APRIL FUND, LTD.

21 APRIL FUND, L.P.

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

FIRST EAGLE HOLDINGS, INC.

  • 10% Owner
22,381,546 2016-09-26 0

SHEPARD JAY

  • Director
0 2016-06-22 0

YUM SU IL EXEC. VP PHARM./R&D

  • Officer
0 2015-01-09 0

CASEY MICHAEL D

  • Director
0 2013-06-25 0

MENDENHALL PAULA V EXEC. VP OF OPERATIONS/ADMIN.

  • Officer
0 2012-02-03 0

LIU JEAN I CHIEF LEGAL OFFICER

  • Officer
184,627 2011-01-28 0

STAUFFER JOSEPH WILLIAM CMO AND EXEC.VP CORP. STRATEGY

  • Officer
0 2011-01-20 0

LANGECKER PETER CHIEF MEDICAL OFFICER

  • Officer
0 2009-05-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
DURECT CORPORATION DRRX 2021-11-26 22:15:03 UTC -0.2055 0.2755 5500000
DURECT CORPORATION DRRX 2021-11-26 21:45:03 UTC -0.2055 0.2755 5500000
DURECT CORPORATION DRRX 2021-11-26 21:15:03 UTC -0.2055 0.2755 5500000
DURECT CORPORATION DRRX 2021-11-26 20:45:03 UTC -0.2055 0.2755 5500000
DURECT CORPORATION DRRX 2021-11-26 20:15:03 UTC -0.2055 0.2755 5500000
DURECT CORPORATION DRRX 2021-11-26 19:45:04 UTC -0.2055 0.2755 5500000
DURECT CORPORATION DRRX 2021-11-26 19:15:03 UTC -0.2055 0.2755 5500000
DURECT CORPORATION DRRX 2021-11-26 18:45:04 UTC -0.2078 0.2778 5500000
DURECT CORPORATION DRRX 2021-11-26 18:15:04 UTC -0.2078 0.2778 5500000
DURECT CORPORATION DRRX 2021-11-26 17:45:03 UTC -0.2078 0.2778 5500000
DURECT CORPORATION DRRX 2021-11-26 17:15:03 UTC -0.2078 0.2778 5500000
DURECT CORPORATION DRRX 2021-11-26 16:45:03 UTC -0.2165 0.2865 5500000
DURECT CORPORATION DRRX 2021-11-26 16:15:03 UTC -0.2165 0.2865 5500000
DURECT CORPORATION DRRX 2021-11-26 15:45:03 UTC -0.2165 0.2865 5500000
DURECT CORPORATION DRRX 2021-11-26 15:15:02 UTC -0.2165 0.2865 5500000
DURECT CORPORATION DRRX 2021-11-26 14:45:03 UTC -0.2503 0.3203 5500000
DURECT CORPORATION DRRX 2021-11-26 14:15:03 UTC -0.2503 0.3203 5500000
DURECT CORPORATION DRRX 2021-11-26 13:45:04 UTC -0.2503 0.3203 5500000
DURECT CORPORATION DRRX 2021-11-26 13:15:03 UTC -0.2503 0.3203 5500000
DURECT CORPORATION DRRX 2021-11-26 12:45:04 UTC -0.2503 0.3203 5500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments